0.00 (0.00%) 1d

Related posts

Most Anticipated Earnings: UNC-T, DAN-X and more Canadian Companies Reporting Earnings this Week (Nov 27-Dec 01)
He likes the company still. Out of Latin America, they will probably take the lead. The sector is going through consolidation and it is a time to go shopping. He would look more at Charlotte's Web who has solid earnings. However, below $1.00 there is still value for it. Latin America doesn't have the same perception there than here. They just got licenses from Brazil and Colombia. (Analysts’ price target is $3.25)
He got stopped out of this. If you still own it, wait and hold. Cannabis is going through a normal consolidation. Maybe average down during tax-loss selling. He still likes it. Has a $3 target. They're becoming more of a marketing company and getting into pharmaceutical. They're in Colombia where CBD dominates the weed sector which will be a stepping stone to the rest of the world. Also, in Colombia the energy cost is zero.
They're weed producers from Colombia where growing weed is easy. Khiron has a great brand in Colombia. Massive sales going into Europe and mostly Latin America. (Analysts’ price target is $6.38)

They are focused on the medical market in Columbia and more generally in Latin America. They are positioned to be one of the first Columbia-based companies to have product in the domestic market. Their CEO used to manage infrastructure projects for SNC. The other co-founder launched Advil into the country. Another executive has years of experience in the US Drug Enforcement Agency. This is a knowledgeable management team. They plan to replicate their model of doctor engagement throughout South America and Mexico.

Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Khiron Life Sciences(KHRN-X) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Khiron Life Sciences is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Khiron Life Sciences(KHRN-X) Frequently Asked Questions

What is Khiron Life Sciences stock symbol?

Khiron Life Sciences is a Canadian stock, trading under the symbol KHRN-X on the TSX Venture Exchange (KHRN-CV). It is usually referred to as TSXV:KHRN or KHRN-X

Is Khiron Life Sciences a buy or a sell?

In the last year, there was no coverage of Khiron Life Sciences published on Stockchase.

Is Khiron Life Sciences a good investment or a top pick?

Khiron Life Sciences was recommended as a Top Pick by on . Read the latest stock experts ratings for Khiron Life Sciences.

Why is Khiron Life Sciences stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Khiron Life Sciences worth watching?

0 stock analysts on Stockchase covered Khiron Life Sciences In the last year. It is a trending stock that is worth watching.

What is Khiron Life Sciences stock price?

On 2023-05-05, Khiron Life Sciences (KHRN-X) stock closed at a price of $0.04.